Does epilepsy occur more frequently in children with Type 1 diabetes?

Michele A O'Connell1, A Simon Harvey, Mark T Mackay

  • 1Department of Endocrinology and Diabetes, Royal Children's Hospital, Victoria, Australia. michele.oconnell@rch.org.au

Insights

Children with Type 1 diabetes do not have a higher risk of developing epilepsy compared to the general pediatric population. This study found similar epilepsy prevalence in diabetic children, addressing concerns about seizure thresholds.

Area of Science:

  • Pediatric Neurology
  • Endocrinology
  • Epileptology

Background:

  • Hypoglycemic seizures and EEG abnormalities are known in children with diabetes.
  • Glutamic acid decarboxylase antibodies, linked to Type 1 diabetes, are implicated in neurological disorders.
  • The risk of epilepsy in children with diabetes remains understudied.

Purpose of the Study:

  • To determine the prevalence and types of epilepsy in children and adolescents with Type 1 diabetes.
  • To investigate if children with diabetes have a higher predisposition to epilepsy.
  • To assess the relationship between diabetes and epilepsy in a pediatric cohort.

Main Methods:

  • Chart review audit conducted at a large pediatric diabetes clinic.
  • Inclusion of clinical, demographic, biochemical, EEG, and neuro-imaging data.
  • Analysis of data from 1384 children and adolescents aged 0-19 years with Type 1 diabetes.

Main Results:

  • Twelve cases of active epilepsy were identified, yielding a prevalence of 8.7 per 1000 children.
  • The majority of epilepsy cases involved idiopathic generalized epilepsy and benign focal epilepsy of childhood.
  • The observed prevalence of epilepsy in this cohort is comparable to the general pediatric population.

Conclusions:

  • Childhood epilepsy occurs with similar frequency in children with Type 1 diabetes as in the general pediatric population.
  • There is no increased risk of epilepsy in pediatric patients with Type 1 diabetes.
  • Further research may explore specific epilepsy syndromes in this population.
Abstract

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...